# Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

> **NCT04838288** · PHASE4 · COMPLETED · sponsor: **Vanderbilt University Medical Center** · enrollment: 56 (actual)

## Conditions studied

- Renal Transplant

## Interventions

- **DRUG:** Change from Prograf to Envarsus XR

## Key facts

- **NCT ID:** NCT04838288
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-22
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-10-22
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04838288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04838288, "Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04838288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*